Had my second AZ vaccine today. Feeling a bit achey & virally, but not yet as bad as last time, that was awful. I've still not had a sick day since 2007 and believe in keeping as well as possible.
Fortunately as a front line worker I'm now jabbed up and hopefully the rest of the population will be soon.
This disease has killed an A&E nurse I worked with.
On the general subject of vaccines I've always had them, especially when traveling abroad. I had about 8 when I went to India costing around £500 each for me and the misses. Some diseases aren't worth risky life for.
The fall in the pound comes after it was revealed AstraZeneca will hand over all of its vaccines made in the Netherlands to the EU - despite the UK having a claim to the doses.
EU vaccine tsar Thierry Breton said the firm has agreed to send six million doses to the bloc every month from its Halix plant in Leiden.
This factory has been at the centre of a vaccine war between Britain and the EU because the UK has a contractual claim to for it to fulfil orders of the Oxford-produced jab
Downing Street had offered to share production capacity at the facility with Brussels.
But Mr Breton has now confirmed AstraZeneca CEO Pascal Soriot had acknowledged all but one batch made at the plant will be sent to EU member states.
The European Medicines Agency said on Friday that it has started a review to assess blood clots in people who received Johnson & Johnson’s Covid-19 vaccine.
One of the blood clot cases following the J&J jab happened during a clinical trial. At the time, the company responded saying it had found no evidence the vaccine was at fault.
The three other cases occurred in the United States, where the shot has been given to almost 5 million people.
Though the J&J vaccine is approved in the EU, its rollout in the bloc isn't expected to start until later this month.
However, the EU is relying on the single-shot vaccine to boost its Covid-19 immunization programme amid restrictions in some countries on use of the AstraZeneca jab, which is administered in two doses, for certain age groups.
In general though, now that the most vulnerable have been vaccinated in the U.K., it makes sense for more of the locally manufactured vaccine supply to be allocated to the most vulnerable citizens of our near neighbours. Win win in terms of preventing new strains reaching us and hopefully speeds up the end of travel restrictions.
In general though, now that the most vulnerable have been vaccinated in the U.K., it makes sense for more of the locally manufactured vaccine supply to be allocated to the most vulnerable citizens of our near neighbours. Win win in terms of new strains reaching us and hopefully speeds up the end of travel restrictions.
Could not agree more. Whilst I would like a vaccine, and although I have mild asthma, statistically I have a vanishingly small chance of dying from Covid. I'd sooner death was.prevented elsewhere. People with weak immune systems are where new strains have time to develop and their need is greater than mine
How much is the vaccine programme expected to slow in the coming months? Seems to be conflicting views. Macron is claiming France will have caught up with the UK in a few weeks vaccine programme - I'm assuming this is in the very least partly to save face from their poor progress so far and he seems pretty intent on blocking doses leaving the EU too.
I suspect Macron means France will catch up the UK on the rate of daily jabs. The French are definitely turning out more daily jabs than they were a couple of weeks back.
It's unlikely we will slow so much that France will catch up on the total, until long after we've finished.
UK Current 1st Jabs = 30,151,287 France Current 1st Jabs = 7,742,466
UK Current 2nd Jabs = 3,527,481 France Current 2nd Jabs = 2,651,777
Previous figures were as at 29th March;
These are the current comparisons;
UK Current 1st jabs = 31,903,366 France Current 1st jabs = 10,148,039
UK Current 2nd jabs = 6,541,174 France Current 2nd jabs = 3,488,124
Some people are just shifting the goal posts and bringing up ''long covid'' and appealing to emotion that children get this virus too with potential side long term effects, they want a full lockdown until near 100% are vaccinated. in that case why aren't we hoarding vaccines like Isreal who get praise for their vaccination campaign. isreal has fans in stadiums now.
I had no reaction at all from my second Astra-Zeneca jab on Thursday, I had feverish symptoms for about fours hours the evening of my first jab. So obviously easier second time around.
Some people are just shifting the goal posts and bringing up ''long covid'' and appealing to emotion that children get this virus too with potential side long term effects, they want a full lockdown until near 100% are vaccinated. in that case why aren't we hoarding vaccines like Isreal who get praise for their vaccination campaign. isreal has fans in stadiums now.
Sigh
'Some people'. Care to quantify that with a number? There are probably about 1,000 people in the country who want a full lockdown until 100% are vaccinated. Stop trying to equate people who think there should be some sensible time frame to lifting restrictions (which, thankfully, the government appear to have got right this time) with people who think that you can catch covid by looking at someone 100 yards away who might have had covid 10 months ago.
I had no reaction at all from my second Astra-Zeneca jab on Thursday, I had feverish symptoms for about fours hours the evening of my first jab. So obviously easier second time around.
@Jessie, although the World Health Organisation was hoping to give its verdict on the Chinese vaccines last month, apparently they are still waiting for China to send them results of all the phase III trials.
In the meantime, you might be interested to read this article from the British Medical Journal, an internationally well-regarded periodical. https://www.bmj.com/content/373/bmj.n912
No definitive answers, but it does summarise information about some of the Chinese vaccines available from other countries where some of the trials have been conducted.
Hope this helps if you are in a position where you and/or your parents need to make decisions.
After the Sunderland game Mrs Plum and I went to New Cross for our second AZ jab, nine weeks and one day after the first. We each were given a little badge rather than a sticker, and our jab cards were filled in. The volunteers were brilliant, even at the end of a long day, where one volunteer said they had done over 1000 people. So far virtually no reaction, not even the arm ache of the first jab, just the very very slightest ‘awareness discomfort’ on the arm.
After the Sunderland game Mrs Plum and I went to New Cross for our second AZ jab, nine weeks and one day after the first. We each were given a little badge rather than a sticker, and our jab cards were filled in. The volunteers were brilliant, even at the end of a long day, where one volunteer said they had done over 1000 people. So far virtually no reaction, not even the arm ache of the first jab, just the very very slightest ‘awareness discomfort’ on the arm.
Interesting feedback from Israel regarding ‘vaccine passports’.
Appears that over-60s were, in the main, happy to get a vaccine.
However, younger people were not as they did not perceive sufficient benefit. This changed when the green pass was announced, which would give the holder access to restaurants bars music venues etc.
Now nearly all Israeli adults have a vaccine passport ... yet few venues are bothering to enforce it because they know almost everyone is now vaccinated.
So the passport has been used as a carrot to ensure uptake of the vaccine and it has succeeded.
I get the impression that this is the approach now bring taken in the U.K.
Had my second vaccine (Pfizer) on Friday - I'm only 23 but was able to have it because I'm a medical student in my placement years. Felt feverish and fluey after my first jab in January but completely fine after this one. Glad to have had both lots now, as are my housemates.
Think younger people would be more inclined to have the vaccine, when it's rolled out to all adults, if more emphasis was put the on the reduction of transmission. Although they say about protecting your loved ones etc I feel like the emphasis has mainly been put on protection of deaths directly (rightly). I don't really think that vaccine passports/covid certificates in our own country is a good idea. Even though I've had both jabs I don't want to have to carry round some private information on myself to do things which should be considered normal. I know this is unprecedented times and I don't doubt that the intention of a vaccine passport is good, but think we have to be careful that this doesn't become a normal thing forever - it's easy enough to show a sort of slippery slope argument to having to carry around some form of ID/pass with you all the time.
Interesting feedback from Israel regarding ‘vaccine passports’.
Appears that over-60s were, in the main, happy to get a vaccine.
However, younger people were not as they did not perceive sufficient benefit. This changed when the green pass was announced, which would give the holder access to restaurants bars music venues etc.
Now nearly all Israeli adults have a vaccine passport ... yet few venues are bothering to enforce it because they know almost everyone is now vaccinated.
So the passport has been used as a carrot to ensure uptake of the vaccine and it has succeeded.
I get the impression that this is the approach now bring taken in the U.K.
Yeah, I posted that a few weeks back. If it's pushed as a sort of 'level unlock' instead of a 'passport', it's much more likely to be adopted by the young.
Had my second vaccine (Pfizer) on Friday - I'm only 23 but was able to have it because I'm a medical student in my placement years. Felt feverish and fluey after my first jab in January but completely fine after this one. Glad to have had both lots now, as are my housemates.
Think younger people would be more inclined to have the vaccine, when it's rolled out to all adults, if more emphasis was put the on the reduction of transmission. Although they say about protecting your loved ones etc I feel like the emphasis has mainly been put on protection of deaths directly (rightly). I don't really think that vaccine passports/covid certificates in our own country is a good idea. Even though I've had both jabs I don't want to have to carry round some private information on myself to do things which should be considered normal. I know this is unprecedented times and I don't doubt that the intention of a vaccine passport is good, but think we have to be careful that this doesn't become a normal thing forever - it's easy enough to show a sort of slippery slope argument to having to carry around some form of ID/pass with you all the time.
I think that is a perfectly understandable and natural point of view to have if you're younger. I'm sort of stuck in that no-man's-land between 'young and carefree' and 'miserable old fecker' (although I've always been pretty miserable 🤣) and I can see both viewpoints.
Had my second vaccine (Pfizer) on Friday - I'm only 23 but was able to have it because I'm a medical student in my placement years. Felt feverish and fluey after my first jab in January but completely fine after this one. Glad to have had both lots now, as are my housemates.
Think younger people would be more inclined to have the vaccine, when it's rolled out to all adults, if more emphasis was put the on the reduction of transmission. Although they say about protecting your loved ones etc I feel like the emphasis has mainly been put on protection of deaths directly (rightly). I don't really think that vaccine passports/covid certificates in our own country is a good idea. Even though I've had both jabs I don't want to have to carry round some private information on myself to do things which should be considered normal. I know this is unprecedented times and I don't doubt that the intention of a vaccine passport is good, but think we have to be careful that this doesn't become a normal thing forever - it's easy enough to show a sort of slippery slope argument to having to carry around some form of ID/pass with you all the time.
I think that is a perfectly understandable and natural point of view to have if you're younger. I'm sort of stuck in that no-man's-land between 'young and carefree' and 'miserable old fecker' (although I've always been pretty miserable 🤣) and I can see both viewpoints.
Had my second vaccine (Pfizer) on Friday - I'm only 23 but was able to have it because I'm a medical student in my placement years. Felt feverish and fluey after my first jab in January but completely fine after this one. Glad to have had both lots now, as are my housemates.
Think younger people would be more inclined to have the vaccine, when it's rolled out to all adults, if more emphasis was put the on the reduction of transmission. Although they say about protecting your loved ones etc I feel like the emphasis has mainly been put on protection of deaths directly (rightly). I don't really think that vaccine passports/covid certificates in our own country is a good idea. Even though I've had both jabs I don't want to have to carry round some private information on myself to do things which should be considered normal. I know this is unprecedented times and I don't doubt that the intention of a vaccine passport is good, but think we have to be careful that this doesn't become a normal thing forever - it's easy enough to show a sort of slippery slope argument to having to carry around some form of ID/pass with you all the time.
I suppose the flipside to that is that you (as a 23 year old) presumably would already carry around id to show you're over 18 in order to buy alcohol
Similarly if doing major financial transactions in the bank, they'll require id like a driving license or a passport, so we're already having to carry around id on many occasions
Following effective clinical trial results and millions of successful vaccinations with mRNA-based COVID-19 vaccines, researchers now are looking into how the discovery could make way for other coveted treatments.
Scientists are gearing up to study mRNA for cancer and HIV treatment
Scientists at The University of Texas MD Anderson Cancer Center are preparing to study mRNA as a cancer treatment right now.
They believe mRNA could be used to prevent cancer recurrence, Dr. Van Morris, an oncologist heading the clinical trial, said in a recent article on the MD Anderson website.
The likelihood of cancer recurring varies based on the type of cancer, and is most common with ovarian cancer, bladder cancer, and glioblastoma. Recurrence happens when small amounts of cancer cells stay in the body after treatment, multiply, and in some cases move to other areas of the body.
In the trial, which is currently in its second phase, doctors test cancer patients who had tumors removed and went through chemotherapy. Once tests reveal cancer cells that are still circulating throughout their bodies, the researchers create individualized mRNA cocktails.
"We're hopeful that with the personalized vaccine, we're priming the immune system to go after the residual tumor cells, clear them out and cure the patient," said Morris.
Scientists at Scripps University in California are also looking at HIV, a sexually transmitted infection that affects 1.2 million people worldwide, as a candidate for an mRNA vaccine.
Similar to the way the COVID-19 vaccine attaches to spiky coronavirus proteins and kills them, the HIV vaccine could do the same with HIV particles, William Schief, an immunologist at Scripps Research who helped develop the HIV vaccine in a Phase 1 trial, said in a press release.
Now that Schief's team knows mRNA can be used to target and kill HIV, they'll use that technology in future studies in the hopes of soon creating an HIV vaccine.
Since the advent of the COVID-19 vaccine, researchers have also pivoted to diseases they anticipate will become greater threats in the coming years.
The Oxford University scientists who collaborated with AstraZeneca to develop their COVID-19 vaccine are now working on a vaccine to treat the sexually transmitted disease gonorrhea, Insider previously reported.
Comments
The UK has begun the rollout of its third coronavirus vaccine, the Moderna jab, in Wales.
Unpaid carer Elle Taylor said she was "very excited and happy" to be the first in the UK to receive the jab.
In England, small business minister Paul Scully said the vaccine will be rolled out "in the next few days".
Nice to see he's moved up in the world and is now overseeing more small businesses than just Gillingham.
Fortunately as a front line worker I'm now jabbed up and hopefully the rest of the population will be soon.
This disease has killed an A&E nurse I worked with.
On the general subject of vaccines I've always had them, especially when traveling abroad. I had about 8 when I went to India costing around £500 each for me and the misses. Some diseases aren't worth risky life for.
The fall in the pound comes after it was revealed AstraZeneca will hand over all of its vaccines made in the Netherlands to the EU - despite the UK having a claim to the doses.
EU vaccine tsar Thierry Breton said the firm has agreed to send six million doses to the bloc every month from its Halix plant in Leiden.
This factory has been at the centre of a vaccine war between Britain and the EU because the UK has a contractual claim to for it to fulfil orders of the Oxford-produced jab
Downing Street had offered to share production capacity at the facility with Brussels.
But Mr Breton has now confirmed AstraZeneca CEO Pascal Soriot had acknowledged all but one batch made at the plant will be sent to EU member states.
https://www.msn.com/en-gb/money/other/pound-set-to-plummet-to-biggest-loss-in-seven-months-as-fears-grow-over-astrazeneca-supply/ar-BB1fsMVY?li=AAnZ9Ug
No surprise in these dark days.
One of the blood clot cases following the J&J jab happened during a clinical trial. At the time, the company responded saying it had found no evidence the vaccine was at fault.
The three other cases occurred in the United States, where the shot has been given to almost 5 million people.
Though the J&J vaccine is approved in the EU, its rollout in the bloc isn't expected to start until later this month.
However, the EU is relying on the single-shot vaccine to boost its Covid-19 immunization programme amid restrictions in some countries on use of the AstraZeneca jab, which is administered in two doses, for certain age groups.
https://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-news-vaccine-astrazeneca-covid-blood-clots-cases/
In general though, now that the most vulnerable have been vaccinated in the U.K., it makes sense for more of the locally manufactured vaccine supply to be allocated to the most vulnerable citizens of our near neighbours. Win win in terms of preventing new strains reaching us and hopefully speeds up the end of travel restrictions.
These are the current comparisons;
UK Current 1st jabs = 31,903,366
France Current 1st jabs = 10,148,039
UK Current 2nd jabs = 6,541,174
France Current 2nd jabs = 3,488,124
'Some people'. Care to quantify that with a number? There are probably about 1,000 people in the country who want a full lockdown until 100% are vaccinated. Stop trying to equate people who think there should be some sensible time frame to lifting restrictions (which, thankfully, the government appear to have got right this time) with people who think that you can catch covid by looking at someone 100 yards away who might have had covid 10 months ago.
The UK has reported the largest number of second coronavirus vaccine doses given in a single day, according to the latest government data.
A total of 450,136 second doses were received on Friday - with 106,878 first doses also administered.
The previous record was set on Thursday when 449,269 second doses were reported - in addition to 96,242 first doses.
https://www.bbc.co.uk/news/uk-56704539
In the meantime, you might be interested to read this article from the British Medical Journal, an internationally well-regarded periodical. https://www.bmj.com/content/373/bmj.n912
No definitive answers, but it does summarise information about some of the Chinese vaccines available from other countries where some of the trials have been conducted.
Hope this helps if you are in a position where you and/or your parents need to make decisions.
We each were given a little badge rather than a sticker, and our jab cards were filled in.
The volunteers were brilliant, even at the end of a long day, where one volunteer said they had done over 1000 people.
So far virtually no reaction, not even the arm ache of the first jab, just the very very slightest ‘awareness discomfort’ on the arm.
Think younger people would be more inclined to have the vaccine, when it's rolled out to all adults, if more emphasis was put the on the reduction of transmission. Although they say about protecting your loved ones etc I feel like the emphasis has mainly been put on protection of deaths directly (rightly). I don't really think that vaccine passports/covid certificates in our own country is a good idea. Even though I've had both jabs I don't want to have to carry round some private information on myself to do things which should be considered normal. I know this is unprecedented times and I don't doubt that the intention of a vaccine passport is good, but think we have to be careful that this doesn't become a normal thing forever - it's easy enough to show a sort of slippery slope argument to having to carry around some form of ID/pass with you all the time.
Similarly if doing major financial transactions in the bank, they'll require id like a driving license or a passport, so we're already having to carry around id on many occasions
More than 400,000 second doses of Covid vaccines have been given in the UK for the fourth consecutive day, according to the latest government data.
A record total of 475,230 second doses were administered on Saturday - along with 111,109 first doses.
On Friday, 450,136 second doses and 106,878 first doses were received.
https://www.bbc.co.uk/news/uk-56709870
Scientists are experimenting with COVID-19 vaccine technology as a way to treat terminal illnesses like cancer and HIV, Inverse reported.
That's because the coronavirus pandemic pushed scientists to create a first-of-its-kind vaccine using mRNA, or a small piece of a coronavirus particle's spike protein, to create an immune system response that protects from infection.
It's an approach vaccine researchers have been studying for the past 25 years, Insider previously reported.
Following effective clinical trial results and millions of successful vaccinations with mRNA-based COVID-19 vaccines, researchers now are looking into how the discovery could make way for other coveted treatments.
Scientists are gearing up to study mRNA for cancer and HIV treatment
Scientists at The University of Texas MD Anderson Cancer Center are preparing to study mRNA as a cancer treatment right now.
They believe mRNA could be used to prevent cancer recurrence, Dr. Van Morris, an oncologist heading the clinical trial, said in a recent article on the MD Anderson website.
The likelihood of cancer recurring varies based on the type of cancer, and is most common with ovarian cancer, bladder cancer, and glioblastoma. Recurrence happens when small amounts of cancer cells stay in the body after treatment, multiply, and in some cases move to other areas of the body.
In the trial, which is currently in its second phase, doctors test cancer patients who had tumors removed and went through chemotherapy. Once tests reveal cancer cells that are still circulating throughout their bodies, the researchers create individualized mRNA cocktails.
"We're hopeful that with the personalized vaccine, we're priming the immune system to go after the residual tumor cells, clear them out and cure the patient," said Morris.
Scientists at Scripps University in California are also looking at HIV, a sexually transmitted infection that affects 1.2 million people worldwide, as a candidate for an mRNA vaccine.
Similar to the way the COVID-19 vaccine attaches to spiky coronavirus proteins and kills them, the HIV vaccine could do the same with HIV particles, William Schief, an immunologist at Scripps Research who helped develop the HIV vaccine in a Phase 1 trial, said in a press release.
Now that Schief's team knows mRNA can be used to target and kill HIV, they'll use that technology in future studies in the hopes of soon creating an HIV vaccine.
Since the advent of the COVID-19 vaccine, researchers have also pivoted to diseases they anticipate will become greater threats in the coming years.
The Oxford University scientists who collaborated with AstraZeneca to develop their COVID-19 vaccine are now working on a vaccine to treat the sexually transmitted disease gonorrhea, Insider previously reported.